|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2007;83:202-203
© 2007 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery, Papworth Hospital, Cambridge, CB3 8RE United Kingdom
(Email: eric.lim@cvsnet.org).
| The first 20% of the full text of this article appears below. |
The current international system for staging non-small cell lung cancer [1] is based solely on the anatomical distribution of disease and does not take into account the biological characteristics of the tumor. However, evidence is gathering for the contribution of tumor aggression as detected by histologic grade [2], molecular markers [3], and most recently genomic profile [4].
A relatively well-studied technique is the use of pleural lavage cytology, which fits in between as an
Related Article
Ann. Thorac. Surg. 2007 83: 197-202.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |